171 related articles for article (PubMed ID: 37300745)
21. Endometrial Cancer, BRCA1, and BRCA2 in the UK Biobank Cohort.
Lehrer S; Rheinstein PH
Am J Clin Oncol; 2021 Jul; 44(7):299-300. PubMed ID: 34008499
[TBL] [Abstract][Full Text] [Related]
22. Association of HLA-B Gene Polymorphisms with Type 2 Diabetes in Pashtun Ethnic Population of Khyber Pakhtunkhwa, Pakistan.
Jan A; Saeed M; Afridi MH; Khuda F; Shabbir M; Khan H; Ali S; Hassan M; Samiullah ; Akbar R; Zakiullah
J Diabetes Res; 2021; 2021():6669731. PubMed ID: 34258292
[TBL] [Abstract][Full Text] [Related]
23. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
Parvin S; Islam MS; Al-Mamun MM; Islam MS; Ahmed MU; Kabir ER; Hasnat A
Breast Cancer; 2017 Mar; 24(2):229-237. PubMed ID: 27068824
[TBL] [Abstract][Full Text] [Related]
24. Genetic testing in a cohort of young patients with HER2-amplified breast cancer.
Eccles DM; Li N; Handwerker R; Maishman T; Copson ER; Durcan LT; Gerty SM; Jones L; Evans DG; Haywood L; Campbell I
Ann Oncol; 2016 Mar; 27(3):467-73. PubMed ID: 26681682
[TBL] [Abstract][Full Text] [Related]
25. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
26. Association of nasopharyngeal cancer risk with genetic polymorphisms of drug-metabolizing enzyme genes GSTM1, GSTT1 and CYP1A1 (rs4646903 variant), in tobacco addicted patients of Pashtun ethnicity of Khyber Pakhtunkhwa Province of Pakistan.
Zakiullah -; Saeed M; Javed N; Khuda F; Ovais M
Pak J Pharm Sci; 2019 Sep; 32(5):2107-2116. PubMed ID: 31813877
[TBL] [Abstract][Full Text] [Related]
27. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
[TBL] [Abstract][Full Text] [Related]
28. Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan.
Ullah A; Khan BM; Khan NU; Muntaha ST; Khan S; Khan AU; Almutairi MH; Ali I
Mol Biol Rep; 2023 Dec; 51(1):1. PubMed ID: 38040921
[TBL] [Abstract][Full Text] [Related]
29. BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Monnerat C; Chompret A; Kannengiesser C; Avril MF; Janin N; Spatz A; Guinebretière JM; Marian C; Barrois M; Boitier F; Lenoir GM; Bressac-de Paillerets B
Fam Cancer; 2007; 6(4):453-61. PubMed ID: 17624602
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.
Seong MW; Cho S; Noh DY; Han W; Kim SW; Park CM; Park HW; Kim SY; Kim JY; Park SS
Clin Genet; 2009 Aug; 76(2):152-60. PubMed ID: 19656164
[TBL] [Abstract][Full Text] [Related]
31. Family history and BRCA1/BRCA2 status among Japanese ovarian cancer patients and occult cancer in a BRCA1 mutant case.
Hirasawa A; Masuda K; Akahane T; Ueki A; Yokota M; Tsuruta T; Nomura H; Kataoka F; Tominaga E; Banno K; Makita K; Susumu N; Sugano K; Kosaki K; Kameyama K; Aoki D
Jpn J Clin Oncol; 2014 Jan; 44(1):49-56. PubMed ID: 24218521
[TBL] [Abstract][Full Text] [Related]
32. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Spurdle AB; Marquart L; McGuffog L; Healey S; Sinilnikova O; Wan F; Chen X; Beesley J; Singer CF; Dressler AC; Gschwantler-Kaulich D; Blum JL; Tung N; Weitzel J; Lynch H; Garber J; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Conroy D; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Selkirk CG; Daly M; Isaacs C; Stoppa-Lyonnet D; Sinilnikova OM; Buecher B; Belotti M; Mazoyer S; Barjhoux L; Verny-Pierre C; Lasset C; Dreyfus H; Pujol P; Collonge-Rame MA; ; Rookus MA; Verhoef S; Kriege M; Hoogerbrugge N; Ausems MG; van Os TA; Wijnen J; Devilee P; Meijers-Heijboer HE; Blok MJ; Heikkinen T; Nevanlinna H; Jakubowska A; Lubinski J; Huzarski T; Byrski T; Durocher F; Couch FJ; Lindor NM; Wang X; Thomassen M; Domchek S; Nathanson K; Caligo M; Jernström H; Liljegren A; Ehrencrona H; Karlsson P; ; Ganz PA; Olopade OI; Tomlinson G; Neuhausen S; Antoniou AC; Chenevix-Trench G; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1032-8. PubMed ID: 21393566
[TBL] [Abstract][Full Text] [Related]
33. Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.
Arcand SL; Maugard CM; Ghadirian P; Robidoux A; Perret C; Zhang P; Fafard E; Mes-Masson AM; Foulkes WD; Provencher D; Narod SA; Tonin PN
Breast Cancer Res Treat; 2008 Apr; 108(3):399-408. PubMed ID: 17541742
[TBL] [Abstract][Full Text] [Related]
34. Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.
Basu NN; Ingham S; Hodson J; Lalloo F; Bulman M; Howell A; Evans DG
Fam Cancer; 2015 Dec; 14(4):531-8. PubMed ID: 26239694
[TBL] [Abstract][Full Text] [Related]
35. Associations of transcription factor 7-Like 2 (
Hameed T; Khan Z; Imran M; Ali S; Albegali AA; Ullah MI; Ejaz H
Afr Health Sci; 2021 Mar; 21(1):15-22. PubMed ID: 34394276
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D Receptor Gene Polymorphism: Association with Susceptibility to Early-Onset Breast Cancer in Iranian, BRCA1/2-Mutation Carrier and non-carrier Patients.
Shahabi A; Alipour M; Safiri H; Tavakol P; Alizadeh M; Milad Hashemi S; Shahabi M; Halimi M
Pathol Oncol Res; 2018 Jul; 24(3):601-607. PubMed ID: 28780723
[TBL] [Abstract][Full Text] [Related]
37. Association between 17q21 variants and asthma predisposition in Pashtun population from Pakistan.
Afzal S; Ramzan K; Ullah S; Jamal A; Basit S; AlKattan KM; Waqar AB
J Asthma; 2023 Jan; 60(1):63-75. PubMed ID: 34982638
[TBL] [Abstract][Full Text] [Related]
38. The BRCA1 and BRCA2 Genes in Early-Onset Breast Cancer Patients.
Saleem M; Ghazali MB; Wahab MAMA; Yusoff NM; Mahsin H; Seng CE; Khalid IA; Rahman MNG; Yahaya BH
Adv Exp Med Biol; 2020; 1292():1-12. PubMed ID: 29687286
[TBL] [Abstract][Full Text] [Related]
39. Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.
Ibrahim SS; Hafez EE; Hashishe MM
J Exp Clin Cancer Res; 2010 Jun; 29(1):82. PubMed ID: 20579331
[TBL] [Abstract][Full Text] [Related]
40. Genetic susceptibility to esophageal cancer due to CYP1A1 gene variant rs4646903 in tobacco addicted patients of Pashtun ethnicity: a case control study in Khyber Pakhtunkhwa province of Pakistan.
Zakiullah ; Saeed M; Ali S; Javed N; Khisroon M; Muhammad B; Khuda F; Ahmad S; Ismail M
Asian Pac J Cancer Prev; 2014; 15(16):6715-20. PubMed ID: 25169514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
